Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02282423 · ClinicalTrials.gov registry record · NA
PGC-1 & Muscle Mitochondrial Dysfunction in Diabetes
A NA study, sponsored by Mayo Clinic.
- Terminated
- Registry status
- NA
- Development phase
- 26
- Enrollment target
NCT02282423: Clinical Trial NA study, sponsored by Mayo Clinic.
NCT02282423 is a NA study that was terminated before completion, run by Mayo Clinic. The registered enrollment target is 26 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02282423, a NA study, was terminated before completion, sponsored by Mayo Clinic.
- TERMINATED
- Registry status
- NA
- Development phase
- 26 participants
- Enrollment target
Study Summary
The goal of this study is to understand how and why insulin resistant individuals respond differently to exercise as compared with insulin sensitive individuals at the skeletal muscle and gene expression level.
Interventions
- BEHAVIORAL Pre-study dietary and exercise instruction.
- PROCEDURE Screening examination and oral glucose tolerance test
- PROCEDURE Euglycemic clamp
- PROCEDURE VO2max.
- BEHAVIORAL Acute exercise bout
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 26 participants |
| Start Date | 2014-05 |
| Est. Completion | 2016-04 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02282423
The ClinicalTrials.gov registry entry for NCT02282423 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 26 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 5 interventions - of which Pre-study dietary and exercise instruction. is the first listed.
NCT02282423 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02282423 about?
NCT02282423 is a clinical study titled "PGC-1 & Muscle Mitochondrial Dysfunction in Diabetes". The goal of this study is to understand how and why insulin resistant individuals respond differently to exercise as compared with insulin sensitive individuals at the skeletal muscle and gene expression level.
What is the current status of trial NCT02282423?
This trial is currently terminated. It is a NA study. The enrollment target is 26 participants. The study started on 2014-05. Estimated completion is 2016-04.
What interventions are being tested in trial NCT02282423?
The interventions under investigation include: Pre-study dietary and exercise instruction. (BEHAVIORAL), Screening examination and oral glucose tolerance test (PROCEDURE), Euglycemic clamp (PROCEDURE), VO2max. (PROCEDURE), Acute exercise bout (BEHAVIORAL).
Who is sponsoring clinical trial NCT02282423?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.